NPIJNikko Principal Investments Japan
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Tokyo, Japan, Aug 11, 2005 - (JCNN) - Nikko Principal Investments Japan (NPIJ) and AnGes MG jointly announced on August 10 that the two companies have agreed to collaborate in the fields of pharmaceutical, medical care and biotechnology, and established a joint investment fund, Bio Sight Innovation No.1 Investment Business Limited Partnership.
The new 2.5 billion yen ($22 mil) fund, to which NPIJ and AnGes MG contribute 1.5 billion yen ($13 mil) and 1 billion yen ($9 mil), respectively, mainly targets pharmaceutical and medical companies as well as bio-venture companies in Japan and overseas.